Publication | Closed Access

Fluorescence In Situ Hybridization Monitoring of BCR-ABL-Positive Neutrophils in Chronic-Phase Chronic Myeloid Leukemia Patients during the Primary Stage of Imatinib Mesylate Therapy

Hematological MalignancyOncologyMedicineImmunologyHematologyMyeloid NeoplasiaImatinib Mesylate TherapyBcr-abl-positive NeutrophilsMolecular DiagnosticsCell BiologyCancer ResearchSitu Hybridization Monitoring